文献综述(Review)

JAK2-STAT3信号通路在肝细胞癌中的研究进展

Published at: 2017年第26卷第1期

廖明媚 1 , 王成志 1 , 杨满意 1 , 潘一峰 1 , 赵劲风 1
1 中南大学湘雅医院 卫生部纳米生物技术重点实验室,湖南 长沙 410008
通讯作者 劲风 赵 Email: zhaojinfeng@hotmail.com
DOI: 10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2017.01.017
基金:
国家自然科学基金资助项目 81302075;81272193;81402001

摘要

近年来发现,JAK2-STAT3信号通路参与肿瘤细胞的生长、增殖、分化、转移、凋亡。在肝细胞癌(HCC)细胞中的JAK蛋白和STAT蛋白过表达,JAK2-STAT3信号通路与HCC发生发展密切相关。笔者就JAK2-STAT3信号通路在HCC的研究进展做一综述。


Research progress of JAK2-STAT3 signing pathway in hepatocellular carcinoma

Abstract

In recent years, JAK2-STAT3 signaling pathway has been found to be involved in the growth, proliferation, differentiation, metastasis and apoptosis of tumor cells. JAK and STAT proteins are overexpressed in hepatocellular carcinoma (HCC) cells, and JAK2-STAT3 signaling pathway is closely related to the occurrence and development of HCC. In this article, the authors overview the research progress of JAK2-STAT3 signaling pathway in HCC.


comments powered by Disqus

全文

引用

引用本文: 明媚 廖, 成志 王, 满意 杨, 一峰 潘, 劲风 赵. JAK2-STAT3信号通路在肝细胞癌中的研究进展 [J]. 中国普通外科杂志, 2017, 26(1): 102-108.
Cite this article as: LIAO Mingmei, WANG Chengzhi, YANG Manyi, PAN Yifeng, ZHAO Jinfeng . Research progress of JAK2-STAT3 signing pathway in hepatocellular carcinoma [J]. Chin J Gen Surg, 2017, 26(1): 102-108.